I won't say who, or I will be lynched by the usual trolls, but another Aussie stem-cell company (with other technologies too) got some Aussie medium-sized private wealth and small bio-tech fund investment buying interest today - a direct strategic placement. Rising tide and all that....
We all know the science in these companies. Their commercialisation of it is tardy at best and investor interest in Australia is accordingly very lacklustre amongst professionals. Probably the most decent and almost lone small cap bio-tech analyst (who I had the pleasures of beers with - he was subsequently right and I was wrong on our MSB/CYP discussion) in Australia was very negative on MSB on its 2020 highs, correctly so.
Much of the Aussie bio-tech and stem cell sector particularly, so low because a sheer lack of Institutional investment interest. And that out there a bit short-sighted - CSL shed some nearly $10 billion in mkt cap recently on a trial fail that wasn't entirely surprising to many.
You get a sniff of a hundredth of that sort of money at these micro-caps and they are going take off.
Stem Cell News, page-511
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12792 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 32500 | 1 |
View Market Depth
| Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |